Solvay's Stock Surpasses Its Bollinger Bands After a 6% Jump in a Week
The stock of the Belgian chemical company listed in Brussels and Paris is trading at €28.32 this Friday, showing a 2.91% increase from the previous day's close. This acceleration brings the weekly performance to over 6%, in a generally supportive European market environment, with the CAC 40 gaining 0.79% during the session.
At €28.32, Solvay's stock now moves above the upper boundary of the Bollinger Bands, set at €27.79. This breach, which places the stock at about 117% of the band, constitutes a potential technical signal of overbuying. The price has also crossed the resistance threshold identified at €27.98, reinforcing the notion of a pronounced short-term bullish dynamic.
Simultaneously, the RSI stands at 63, a level that remains in the high-neutral zone without reaching the critical threshold of 70 generally associated with overbuying. The stock is significantly above its 20-day (€26.20), 50-day (€26.53), and 200-day (€27.37) moving averages, indicating a bullish alignment of trend indicators. The low beta of 0.10 also shows a very limited correlation with general market fluctuations, suggesting that the day's movement is more related to factors specific to the stock than to a market index effect.
Three-Month and Annual Performance
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Over three months, the stock has gained 4.89%, but the annual performance remains negative at -4.07%, reminding that the specialized chemical group's stock market journey has gone through a prolonged consolidation phase. The monthly volatility, measured at 8.06, remains contained, which puts the recent movements into perspective compared to the stock's history.
The next major events for shareholders are scheduled for May 7 with the publication of the first quarter 2026 results, followed by the general meeting on May 12. These dates will be crucial to confirm — or not — the operational trajectory of the group after its spin-off from Syensqo. The SBF 120, the index to which the stock belongs, is up 0.80% in the session, while Schneider Electric, another European industrial, is up 1.80% for the day.
Challenging market environment, excluding potential recovery measures from Sadara, updated guidance reflects Middle East impact
Risks mentioned
Middle East conflict impact of approximately €-25 million on underlying EBITDA in Q3 2026
Continued shutdown of the Peroxide plant at the Sadara complex in Jubail, Saudi Arabia accounted for €-15 million in Q3 2026
Challenging market environment affecting Group performance in Q3 2026
Opportunities identified
Joint venture contractual framework includes mechanisms designed to recover lost profitability from Sadara shutdown
Group exploring all available avenues to mitigate financial impact of shutdown
Transformation program and focus on cash generation and cost savings targets
Outlook / guidance
Expected EBITDA: 730 millions d'euros
Management commentary: In light of these developments, Solvay has reviewed its full-year 2026 guidance. Excluding potential revenue or recovery measures from Sadara for the remainder of 2026, the updated guidance is: Underlying EBITDA between €720 and €740 million
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
